Ernexa Therapeutics, Inc. (ERNA)
2.34
-0.15
(-6.02%)
USD |
NASDAQ |
Oct 09, 16:00
2.34
0.00 (0.00%)
After-Hours: 16:14
Ernexa Therapeutics Price : 2.34 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 2.40 | 2.70 | 2.12 | 2.49 | 214741.0 |
| Oct 07, 2026 | 2.25 | 2.39 | 2.150 | 2.39 | 662924.0 |
| Oct 06, 2026 | 2.75 | 2.96 | 2.20 | 2.235 | 91550.00 |
| Oct 05, 2026 | 3.04 | 3.058 | 2.70 | 2.70 | 21553.00 |
| Oct 02, 2026 | 3.00 | 3.280 | 2.90 | 2.96 | 40810.00 |
| Oct 01, 2026 | 3.13 | 3.236 | 2.84 | 2.96 | 35742.00 |
| Sep 30, 2026 | 3.24 | 3.47 | 3.16 | 3.20 | 42635.00 |
| Sep 29, 2026 | 3.738 | 3.738 | 3.044 | 3.16 | 61865.00 |
| Sep 28, 2026 | 3.46 | 3.500 | 3.20 | 3.47 | 25791.00 |
| Sep 25, 2026 | 3.73 | 3.848 | 3.40 | 3.445 | 21417.00 |
| Sep 24, 2026 | 3.785 | 3.821 | 3.61 | 3.62 | 11526.00 |
| Sep 23, 2026 | 3.73 | 3.79 | 3.65 | 3.65 | 6237.00 |
| Sep 22, 2026 | 3.960 | 3.960 | 3.76 | 3.80 | 14663.00 |
| Sep 21, 2026 | 4.01 | 4.01 | 3.75 | 3.96 | 13500.00 |
| Sep 18, 2026 | 3.79 | 3.885 | 3.79 | 3.83 | 8277.00 |
| Sep 17, 2026 | 4.04 | 4.08 | 3.714 | 3.76 | 33602.00 |
| Sep 16, 2026 | 4.01 | 4.155 | 3.84 | 3.91 | 22562.00 |
| Sep 15, 2026 | 3.79 | 4.70 | 3.65 | 4.08 | 547184.0 |
| Sep 14, 2026 | 4.13 | 4.40 | 4.13 | 4.27 | 16826.00 |
| Sep 11, 2026 | 4.05 | 4.420 | 4.03 | 4.165 | 19816.00 |
| Sep 10, 2026 | 3.925 | 4.05 | 3.90 | 4.02 | 11381.00 |
| Sep 09, 2026 | 4.20 | 4.23 | 3.97 | 4.02 | 15648.00 |
| Sep 08, 2026 | 4.31 | 4.34 | 4.13 | 4.19 | 18298.00 |
| Sep 04, 2026 | 4.50 | 4.83 | 4.21 | 4.31 | 47569.00 |
| Sep 03, 2026 | 4.494 | 4.728 | 4.40 | 4.53 | 14673.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cerenome, Inc. | 1.93 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
Price Related Metrics
| Price to Book Value | 0.8558 |
| Earnings Yield | -808.7% |
| Market Cap | 2.738M |